1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Canine Atopic Dermatitis Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product
(Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others)
5.2.2. By Mode of
Administration (Topical, Oral, Injectable)
5.2.3. By Distribution
Channel (Veterinary Hospitals/Clinics, Retail, E-commerce)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Product Market Map
5.3.1. By Product
5.3.2. By Mode of Administration
5.3.3. By Distribution Channel
5.3.4. By Region
6. North America Canine Atopic Dermatitis
Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
(Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others)
6.2.2. By Mode of
Administration (Topical, Oral, Injectable)
6.2.3. By Distribution Channel (Veterinary
Hospitals/Clinics, Retail, E-commerce)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Canine Atopic Dermatitis
Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Mode of Administration
6.3.1.2.3. By Distribution Channel
6.3.2. Canada Canine Atopic Dermatitis Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Mode of Administration
6.3.2.2.3. By Distribution Channel
6.3.3. Mexico Canine Atopic Dermatitis Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Mode of Administration
6.3.3.2.3. By Distribution Channel
7. Europe Canine Atopic Dermatitis Market Outlook
7.1. Market Size &
Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
(Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others)
7.2.2. By Mode of
Administration (Topical, Oral, Injectable)
7.2.3. By Distribution Channel (Veterinary
Hospitals/Clinics, Retail, E-commerce)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Canine Atopic Dermatitis
Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Mode of Administration
7.3.1.2.3. By Distribution Channel
7.3.2. United Kingdom Canine Atopic Dermatitis
Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Mode of Administration
7.3.2.2.3. By Distribution Channel
7.3.3. France Canine Atopic Dermatitis Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Mode of Administration
7.3.3.2.3. By Distribution Channel
7.3.4. Italy Canine Atopic Dermatitis Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Mode of Administration
7.3.4.2.3. By Distribution Channel
7.3.5. Spain Canine Atopic Dermatitis Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Mode of Administration
7.3.5.2.3. By Distribution Channel
8. Asia-Pacific Canine Atopic Dermatitis
Market Outlook
8.1. Market Size &
Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
(Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others)
8.2.2. By Mode of
Administration (Topical, Oral, Injectable)
8.2.3. By Distribution Channel (Veterinary
Hospitals/Clinics, Retail, E-commerce)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Canine Atopic Dermatitis Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Mode of Administration
8.3.1.2.3. By Distribution Channel
8.3.2. Japan Canine Atopic Dermatitis Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Mode of Administration
8.3.2.2.3. By Distribution Channel
8.3.3. India Canine Atopic Dermatitis Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Mode of Administration
8.3.3.2.3. By Distribution Channel
8.3.4. Australia Canine Atopic Dermatitis
Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Mode of Administration
8.3.4.2.3. By Distribution Channel
8.3.5. South Korea Canine Atopic Dermatitis
Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Mode of Administration
8.3.5.2.3. By Distribution Channel
9. South America Canine Atopic Dermatitis
Market Outlook
9.1. Market Size &
Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
(Glucocorticoids, Antihistamines, Immunosuppressants, MAbs, Others)
9.2.2. By Mode of
Administration (Topical, Oral, Injectable)
9.2.3. By Distribution Channel (Veterinary
Hospitals/Clinics, Retail, E-commerce)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Canine Atopic Dermatitis Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Mode of Administration
9.3.1.2.3. By Distribution Channel
9.3.2. Argentina Canine Atopic Dermatitis
Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Mode of Administration
9.3.2.2.3. By Distribution Channel
9.3.3. Colombia Canine Atopic Dermatitis
Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Mode of Administration
9.3.3.2.3. By Distribution Channel
10. Middle East and Africa Canine Atopic Dermatitis
Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Glucocorticoids,
Antihistamines, Immunosuppressants, MAbs, Others)
10.2.2. By Mode of Administration
(Topical, Oral, Injectable)
10.2.3. By Distribution Channel (Veterinary Hospitals/Clinics, Retail,
E-commerce)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Canine Atopic Dermatitis
Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Mode of Administration
10.3.1.2.3. By Distribution Channel
10.3.2. Saudi Arabia Canine Atopic Dermatitis
Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Mode of Administration
10.3.2.2.3. By Distribution Channel
10.3.3. UAE Canine Atopic Dermatitis Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Mode of Administration
10.3.3.2.3. By Distribution Channel
10.3.4. Kuwait Canine Atopic Dermatitis Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Product
10.3.4.2.2. By Mode of Administration
10.3.4.2.3. By Distribution Channel
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Porter’s
Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products
14. Competitive Landscape
14.1. Business Overview
14.2. Product Offerings
14.3. Recent Developments
14.4. Financials (As Reported)
14.5. Key Personnel
14.6. SWOT Analysis
14.6.1. Zoetis Inc
14.6.2. Elanco Animal Health Inc
14.6.3. Virbac SA
14.6.4. Toray Industries Inc
14.6.5. AB Science SA
14.6.6. Boehringer Ingelheim GmbH
14.6.7. Kindred Biosciences Inc
15. Strategic
Recommendations
16. About
Us & Disclaimer